These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19446544)

  • 1. Piroxicam accelerates development of colitis in T-cell receptor alpha chain-deficient mice.
    Nishiyori A; Nagakura Y; Ichikawa K
    Eur J Pharmacol; 2009 Aug; 615(1-3):241-5. PubMed ID: 19446544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cytokines in the early stages of chronic colitis in TCR alpha-mutant mice.
    Mizoguchi E; Mizoguchi A; Bhan AK
    Lab Invest; 1997 Mar; 76(3):385-97. PubMed ID: 9121121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T cells from IL-10-deficient mice transfer susceptibility to NSAID-induced Rag colitis.
    Blum AM; Metwali A; Elliott DE; Berg DJ; Weinstock JV
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G320-5. PubMed ID: 15246967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7 exacerbates chronic colitis with expansion of memory IL-7Rhigh CD4+ mucosal T cells in mice.
    Okada E; Yamazaki M; Tanabe M; Takeuchi T; Nanno M; Oshima S; Okamoto R; Tsuchiya K; Nakamura T; Kanai T; Hibi T; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G745-54. PubMed ID: 15550560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.
    Joosten LA; Abdollahi-Roodsaz S; Heuvelmans-Jacobs M; Helsen MM; van den Bersselaar LA; Oppers-Walgreen B; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Jan; 58(1):98-108. PubMed ID: 18163514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbating role of gammadelta T cells in chronic colitis of T-cell receptor alpha mutant mice.
    Nanno M; Kanari Y; Naito T; Inoue N; Hisamatsu T; Chinen H; Sugimoto K; Shimomura Y; Yamagishi H; Shiohara T; Ueha S; Matsushima K; Suematsu M; Mizoguchi A; Hibi T; Bhan AK; Ishikawa H
    Gastroenterology; 2008 Feb; 134(2):481-90. PubMed ID: 18242214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter hepaticus infection triggers inflammatory bowel disease in T cell receptor alphabeta mutant mice.
    Chin EY; Dangler CA; Fox JG; Schauer DB
    Comp Med; 2000 Dec; 50(6):586-94. PubMed ID: 11200563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive validity and immune cell involvement in the pathogenesis of piroxicam-accelerated colitis in interleukin-10 knockout mice.
    Holgersen K; Kvist PH; Hansen AK; Holm TL
    Int Immunopharmacol; 2014 Jul; 21(1):137-47. PubMed ID: 24797915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis.
    Sergerie Y; Rivest S; Boivin G
    J Infect Dis; 2007 Sep; 196(6):853-60. PubMed ID: 17703415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced pro-inflammatory cytokine production in Galphai2-deficient mice on colitis prone and colitis resistant 129Sv genetic backgrounds.
    Bjursten M; Hultgren OH; Hultgren Hörnquist E
    Cell Immunol; 2004 Apr; 228(2):77-80. PubMed ID: 15219458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous chronic colitis in TCR alpha-mutant mice; an experimental model of human ulcerative colitis.
    Bhan AK; Mizoguchi E; Smith RN; Mizoguchi A
    Int Rev Immunol; 2000; 19(1):123-38. PubMed ID: 10723681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
    Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
    Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of TNFR2 expression by CD4(+) T cells exacerbates experimental colitis.
    Dayer Schneider J; Seibold I; Saxer-Sekulic N; Paredes BE; Saurer L; Mueller C
    Eur J Immunol; 2009 Jul; 39(7):1743-53. PubMed ID: 19551899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-7 is essential for lymphopenia-driven turnover of colitogenic CD4(+) memory T cells in chronic colitis.
    Tomita T; Kanai T; Totsuka T; Nemoto Y; Okamoto R; Tsuchiya K; Sakamoto N; Ohteki T; Hibi T; Watanabe M
    Eur J Immunol; 2009 Oct; 39(10):2737-47. PubMed ID: 19637223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the piroxicam-incited model of synchronized colitis in T-cell receptor alpha chain-deficient mice.
    Lange ME; Bescucci DM; Boras VF; Montina T; Inglis GD
    Animal Model Exp Med; 2024 Aug; 7(4):533-543. PubMed ID: 38992956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8(+) T cells.
    Keppler SJ; Theil K; Vucikuja S; Aichele P
    Eur J Immunol; 2009 Jul; 39(7):1774-83. PubMed ID: 19548244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model.
    Arafa HM; Hemeida RA; El-Bahrawy AI; Hamada FM
    Food Chem Toxicol; 2009 Jun; 47(6):1311-7. PubMed ID: 19285535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an effective method for dendritic cell immunotherapy of mouse melanoma.
    Lee TH; Cho HK; Cho YH; Lee MG
    Scand J Immunol; 2009 Aug; 70(2):85-92. PubMed ID: 19630913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental infection in tumor necrosis factor alpha receptor, interferon gamma and interleukin 4 deficient mice by pathogenic Leptospira interrogans.
    Athanazio DA; Santos CS; Santos AC; McBride FW; Reis MG
    Acta Trop; 2008 Jan; 105(1):95-8. PubMed ID: 17991451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bile acid receptor FXR is a modulator of intestinal innate immunity.
    Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S
    J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.